Skip to content
In English |
En español
Search
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-3 of 3 for your search:
Cancer Type/Condition:
Pituitary tumor
Stage/Subtype:
recurrent pituitary tumor
Country:
U.S.A.
Trial Type:
Treatment
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase II Study of Temozolomide in Patients With Invasive Pituitary Tumors
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
18 to 75
Sponsor:
NCI, Pharmaceutical / Industry
Protocol IDs:
UCLA-06-12-080
, 06-12-080, SPRI-UCLA-06-12-080, 07-05-077-01, NCT00601289
2.
Phase II Pilot Study of Rosiglitazone Maleate in Patients With Residual or Recurrent ACTH-Secreting Pituitary Tumor or Newly Diagnosed, Recurrent, or Residual Non-Secreting Pituitary Tumor
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
18 to 65
Sponsor:
NCI
Protocol IDs:
UCLA-0411082-03
, 04-11-082-03, NCT00616642
3.
Targeted Therapy With Lapatinib in Patients With Recurrent Pituitary Tumors Resistant to Standard Therapy
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
Over 18
Sponsor:
Other
Protocol IDs:
18129
, NCT00939523
Select All on Page
Help with Results
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
RSS
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute
